327 related articles for article (PubMed ID: 33267829)
1. A risk score based on pediatric sequential organ failure assessment predicts 90-day mortality in children with Klebsiella pneumoniae bloodstream infection.
Li S; Liu J; Chen F; Cai K; Tan J; Xie W; Qian R; Liu X; Zhang W; Du H; Liu Y; Huang L
BMC Infect Dis; 2020 Dec; 20(1):916. PubMed ID: 33267829
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Analysis of Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in Nontransplant Patients.
Xiao T; Zhu Y; Zhang S; Wang Y; Shen P; Zhou Y; Yu X; Xiao Y
J Infect Dis; 2020 Mar; 221(Suppl 2):S174-S183. PubMed ID: 32176799
[TBL] [Abstract][Full Text] [Related]
5. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.
Giacobbe DR; Del Bono V; Trecarichi EM; De Rosa FG; Giannella M; Bassetti M; Bartoloni A; Losito AR; Corcione S; Bartoletti M; Mantengoli E; Saffioti C; Pagani N; Tedeschi S; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viale P; Viscoli C; Tumbarello M;
Clin Microbiol Infect; 2015 Dec; 21(12):1106.e1-8. PubMed ID: 26278669
[TBL] [Abstract][Full Text] [Related]
7. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic and predictive value of critical illness scores and biomarkers in bloodstream infection-associated pneumonia].
Yan S; Sun L; Lian R; Shen M; Zhao X; Zhang G
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):681-685. PubMed ID: 32684212
[TBL] [Abstract][Full Text] [Related]
9. Pediatric CLIF-SOFA score is the best predictor of 28-day mortality in children with decompensated chronic liver disease.
Bolia R; Srivastava A; Yachha SK; Poddar U
J Hepatol; 2018 Mar; 68(3):449-455. PubMed ID: 29024698
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection.
Chen J; Li J; Huang F; Fang J; Cao Y; Zhang K; Zhou H; Cai J; Cui W; Chen C; Zhang G
BMC Pulm Med; 2023 Mar; 23(1):102. PubMed ID: 36978069
[TBL] [Abstract][Full Text] [Related]
11. Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: a 8-year retrospective study in a large teaching hospital in northern Italy.
Alicino C; Giacobbe DR; Orsi A; Tassinari F; Trucchi C; Sarteschi G; Copello F; Del Bono V; Viscoli C; Icardi G
BMC Infect Dis; 2015 Oct; 15():415. PubMed ID: 26464061
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance and virulence factors of Klebsiella pneumoniae affecting 30 day mortality in patients with bloodstream infection.
Kim D; Park BY; Choi MH; Yoon EJ; Lee H; Lee KJ; Park YS; Shin JH; Uh Y; Shin KS; Shin JH; Kim YA; Jeong SH
J Antimicrob Chemother; 2019 Jan; 74(1):190-199. PubMed ID: 30295771
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area.
Cristina ML; Alicino C; Sartini M; Faccio V; Spagnolo AM; Bono VD; Cassola G; De Mite AM; Crisalli MP; Ottria G; Schinca E; Pinto GL; Bottaro LC; Viscoli C; Orsi A; Giacobbe DR; Icardi G;
J Infect Public Health; 2018; 11(2):171-177. PubMed ID: 28668656
[TBL] [Abstract][Full Text] [Related]
14. Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection.
Giannella M; Trecarichi EM; Giacobbe DR; De Rosa FG; Bassetti M; Bartoloni A; Bartoletti M; Losito AR; Del Bono V; Corcione S; Tedeschi S; Raffaelli F; Saffioti C; Spanu T; Rossolini GM; Marchese A; Ambretti S; Cauda R; Viscoli C; Lewis RE; Viale P; Tumbarello M;
Int J Antimicrob Agents; 2018 Feb; 51(2):244-248. PubMed ID: 28842283
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
[TBL] [Abstract][Full Text] [Related]
16. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae.
Anderson DJ; Engemann JJ; Harrell LJ; Carmeli Y; Reller LB; Kaye KS
Antimicrob Agents Chemother; 2006 May; 50(5):1715-20. PubMed ID: 16641440
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections caused by Klebsiella pneumoniae: prevalence of bla
Xu M; Fu Y; Kong H; Chen X; Chen Y; Li L; Yang Q
BMC Infect Dis; 2018 Jul; 18(1):358. PubMed ID: 30064360
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
[TBL] [Abstract][Full Text] [Related]
19. Clinical predictors and outcomes of Klebsiella pneumoniae bacteraemia in a regional hospital in Hong Kong.
Man MY; Shum HP; Chan YH; Chan KC; Yan WW; Lee RA; Lau SKP
J Hosp Infect; 2017 Sep; 97(1):35-41. PubMed ID: 28602703
[TBL] [Abstract][Full Text] [Related]
20. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.
Marra AR; Wey SB; Castelo A; Gales AC; Cal RG; Filho JR; Edmond MB; Pereira CA
BMC Infect Dis; 2006 Feb; 6():24. PubMed ID: 16478537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
